Agence France-Presse

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World ...
Pharmabiz

TreeFrog Therapeutics to present new preclinical data on TFG-001, a 3D neural microtissue cell therapy, at the 7th World Parkinson’s Conference

TreeFrog Therapeutics to present new preclinical data on TFG-001, a 3D neural microtissue cell therapy, at the 7th World Parkinson’s Conference: Bordeaux, France Tuesday, May 26 ...

TreeFrog Therapeutics: TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson's Disease

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinso ...